RE:RE:RE:Results result.Looks dire atm but in fact this represents a catharsis for the Company in the form of a sack of sh*t that needed to be dumped.Balls-up or conspiracy or combination of both this is the elephant in the room that we have all known was there from a similar situation in Phase iB.
All perfectly understandable back then - this is pioneering Science after all - but to now undertreat to such a degree given the optimisation that took place and the multiple built-in safeguards of the compound is frankly unforgiveable.Something has gone badly wrong whether through negligence or design .
The consequence is a farcical sp - this Company has an IND-approved drug and is being free-carried in a major NSCLC Trial not even considering GBM - and perhaps an unwelcome opportunity for predators but more likely this will be swiftly moved on from by those with any understanding of the exceptional nature of the science and the IP stranglehold that TLT has on these next-generation metal based photosensitisers.
In the meantime there are sellers at 16 cents.